Unichem Laboratories receives USFDA approval for Solifenacin Succinate Tablets
Unichem Laboratories has received ANDA
approval from US FDA for Solifenacin Succinate Tablets, 5 mg and 1 0 mg to market
a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US,
Inc. which are indicated for the treatment of overactive bladder with symptoms of
urge urinary incontinence, urgency, and urinary frequency.
The Product will be commercialized from Unichem's Goa plant.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 28 2019 | 8:09 PM IST